BIOF — BLUE BIOFUELS, INC.
—
OTC ·
Materials ·
Chemicals ·
CIK 1549145 ·
Last close
$0.11
Market Cap
$35.85M
52W High
$0.20
52W Low
$0.07
ADV30
318,238
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Jun 2026 | 0 | — | -828,606 | -750,795 | 1,320,959 | 22,040 | 5,379,631 |
| Mar 2026 | 0 | — | -659,498 | -663,801 | 1,309,640 | 8,665 | 5,246,366 |
| Dec 2025 | 0 | — | -1,287,471 | -1,287,469 | 1,407,379 | 65,200 | 5,113,462 |
| Jun 2025 | 0 | — | -902,604 | -920,752 | 1,448,261 | 8,026 | 4,620,330 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-1,391,808
Investing CF
$-106,653
Financing CF
$1,425,750
CapEx
$-203,482
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-0.01
As of
2026-11-15
Balance + Analyst (yfinance extras)
Retained Earnings
$-61,544,958
Inventory
—
Receivables
—
ST Investments
—
EBIT TTM
$-3,580,677
Pretax Income TTM
$-3,622,817
Interest Exp TTM
$42,140
Analysts
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 0 | -2,850,133 | -2,874,601 | 1,407,379 | 5,113,462 | -3,706,083 | -845,002 |
| Dec 2024 | 0 | -3,770,519 | -1,418,981 | 1,389,587 | 4,235,490 | -2,845,903 | -1,003,420 |
| Dec 2023 | 0 | -2,956,256 | -3,055,194 | 1,030,219 | 4,591,301 | -3,561,082 | -1,600,412 |
| Dec 2022 | 0 | -3,892,177 | -3,960,183 | 1,105,919 | 3,462,836 | -2,356,917 | -2,036,143 |
TTM Snapshot
Revenues TTM
$0
NetIncome TTM
$-3,124,612
OpCashFlow TTM
—
Assets (Latest)
$1,320,959
Forward EPS
—
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| UG | UNITED GUARDIAN INC | $34.73M | $7.56 | — |
| AXIL | Axil Brands, Inc. | $33.70M | $4.94 | — |
| LNZA | LanzaTech Global, Inc. | $32.59M | $2.49 | — |
| TANH | TANTECH HOLDINGS LTD | $30.71M | $46.00 | — |
| RAPH | Raphael Pharmaceutical Inc. | $30.47M | $1.51 | — |
News headlines (Yahoo Finance, 1h cache)
Independent Research Report about Blue Biofuels Inc., by Harbinger Research
2026-10-05 15:17 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.